Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and AmyloidosisMorie A. Gertz, G Grateau, Ray Comenzo et al.|American Journal of Hematology|2005Cited by 1.4k
High-Dose Melphalan and Autologous Stem-Cell Transplantation in Patients with AL Amyloidosis: An 8-Year StudyMartha Skinner, Daniel G. Wright, Rodney H. Falk et al.|Annals of Internal Medicine|2004Cited by 615
Systemic immunoglobulin light chain amyloidosisGiampaolo Merlini, Morie A. Gertz, Angela Dispenzieri et al.|Nature Reviews Disease Primers|2018Cited by 550
Consensus guidelines for the conduct and reporting of clinical trials in systemic light-chain amyloidosisRaymond L. Comenzo, Giampaolo Merlini, Donna Reece et al.|Leukemia|2012Cited by 383
Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: long-term results in a series of 421 patientsMaría Teresa Cibeira, Martha Skinner, Vaishali Sanchorawala et al.|Blood|2011Cited by 288